JP2012506394A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012506394A5 JP2012506394A5 JP2011532532A JP2011532532A JP2012506394A5 JP 2012506394 A5 JP2012506394 A5 JP 2012506394A5 JP 2011532532 A JP2011532532 A JP 2011532532A JP 2011532532 A JP2011532532 A JP 2011532532A JP 2012506394 A5 JP2012506394 A5 JP 2012506394A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- tumor
- days
- immune cytokine
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10714608P | 2008-10-21 | 2008-10-21 | |
| US61/107,146 | 2008-10-21 | ||
| PCT/EP2009/007533 WO2010046097A1 (en) | 2008-10-21 | 2009-10-21 | Cancer treatments with radiation and immunocytokines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012506394A JP2012506394A (ja) | 2012-03-15 |
| JP2012506394A5 true JP2012506394A5 (enExample) | 2012-12-06 |
Family
ID=41510762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011532532A Pending JP2012506394A (ja) | 2008-10-21 | 2009-10-21 | 放射線および免疫サイトカインによる癌治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100330029A1 (enExample) |
| EP (1) | EP2337579A1 (enExample) |
| JP (1) | JP2012506394A (enExample) |
| KR (1) | KR20110086101A (enExample) |
| CN (1) | CN102196815A (enExample) |
| AU (1) | AU2009306711A1 (enExample) |
| BR (1) | BRPI0919857A2 (enExample) |
| CA (1) | CA2741130A1 (enExample) |
| EA (1) | EA201100626A1 (enExample) |
| MX (1) | MX2011004193A (enExample) |
| WO (1) | WO2010046097A1 (enExample) |
| ZA (1) | ZA201103726B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015124297A1 (en) * | 2014-02-19 | 2015-08-27 | Merck Patent Gmbh | Cancer-targeted il-12 immunotherapy |
| EP3596108A4 (en) | 2017-03-15 | 2020-12-23 | Pandion Operations, Inc. | TARGETED IMMUNOTOLERANCE |
| US9861833B1 (en) * | 2017-03-30 | 2018-01-09 | Norman H. Anderson | Methods of treating melanoma |
| JP2020521452A (ja) | 2017-05-24 | 2020-07-27 | パンディオン・セラピューティクス・インコーポレイテッド | 標的化免疫寛容 |
| USRE50550E1 (en) | 2017-12-06 | 2025-08-26 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| US10946068B2 (en) | 2017-12-06 | 2021-03-16 | Pandion Operations, Inc. | IL-2 muteins and uses thereof |
| US10174092B1 (en) | 2017-12-06 | 2019-01-08 | Pandion Therapeutics, Inc. | IL-2 muteins |
| EP3972992A4 (en) | 2019-05-20 | 2023-07-19 | Pandion Operations, Inc. | MADCAM TARGETED IMMUNOTLERANCE |
| WO2021168079A1 (en) | 2020-02-21 | 2021-08-26 | Pandion Operations, Inc. | Tissue targeted immunotolerance with a cd39 effector |
| CN112768029B (zh) * | 2020-12-27 | 2023-10-13 | 上海市东方医院（同济大学附属东方医院） | 一种基于单细胞测序的组合用药推荐设备、方法及介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020110538A1 (en) * | 1999-12-28 | 2002-08-15 | Health Research, Inc. | Methods and products for tumor immunotherapy using cytokines |
| PL358582A1 (en) * | 2000-06-29 | 2004-08-09 | Merck Patent Gmbh | Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| EP2354791A1 (en) * | 2001-12-04 | 2011-08-10 | Merck Patent GmbH | Immunocytokines with modulated selectivity |
| RU2007130552A (ru) * | 2005-01-10 | 2009-02-20 | Рисерч Дивелопмент Фаундейшн (US) | Рекомбинантные молекулы направленного действия для лечения рака |
| CN101351475B (zh) * | 2005-12-30 | 2013-05-15 | 默克专利有限公司 | 具有提高的稳定性的白细胞介素12p40变体 |
-
2009
- 2009-10-21 AU AU2009306711A patent/AU2009306711A1/en not_active Abandoned
- 2009-10-21 WO PCT/EP2009/007533 patent/WO2010046097A1/en not_active Ceased
- 2009-10-21 KR KR1020117011503A patent/KR20110086101A/ko not_active Ceased
- 2009-10-21 JP JP2011532532A patent/JP2012506394A/ja active Pending
- 2009-10-21 MX MX2011004193A patent/MX2011004193A/es not_active Application Discontinuation
- 2009-10-21 CA CA2741130A patent/CA2741130A1/en not_active Abandoned
- 2009-10-21 EA EA201100626A patent/EA201100626A1/ru unknown
- 2009-10-21 EP EP09740858A patent/EP2337579A1/en not_active Withdrawn
- 2009-10-21 CN CN2009801417993A patent/CN102196815A/zh active Pending
- 2009-10-21 BR BRPI0919857A patent/BRPI0919857A2/pt not_active IP Right Cessation
- 2009-10-21 US US12/603,363 patent/US20100330029A1/en not_active Abandoned
-
2011
- 2011-05-20 ZA ZA2011/03726A patent/ZA201103726B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012506394A5 (enExample) | ||
| Bae et al. | Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea | |
| JP2013509429A5 (enExample) | ||
| JP2009539769A5 (enExample) | ||
| JP2012087150A5 (enExample) | ||
| NZ630790A (en) | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes | |
| JP2008505857A5 (enExample) | ||
| JP2014530220A5 (enExample) | ||
| JP2013075922A5 (enExample) | ||
| NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
| MX2013015005A (es) | Microparticulas de dicetopiperazina de alta capacidad. | |
| JP2013155188A5 (enExample) | ||
| JP2016539156A5 (enExample) | ||
| JP2015523407A5 (enExample) | ||
| JP2013516493A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2017501140A5 (enExample) | ||
| JP2013518124A5 (enExample) | ||
| JP2016515586A5 (enExample) | ||
| JP2008514577A5 (enExample) | ||
| JP2017512194A5 (enExample) | ||
| JP2015527374A5 (enExample) | ||
| JP2019526559A5 (enExample) | ||
| JP2005522527A5 (enExample) | ||
| JP2013511975A5 (enExample) |